<!DOCTYPE html>
<!-- Generated by pkgdown: do not edit by hand --><html lang="en">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
<meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta name="viewport" content="width=device-width, initial-scale=1.0">
<title>D1 Clinical trials concepts • YESCDS</title>
<!-- jquery --><script src="https://cdnjs.cloudflare.com/ajax/libs/jquery/3.4.1/jquery.min.js" integrity="sha256-CSXorXvZcTkaix6Yvo6HppcZGetbYMGWSFlBw8HfCJo=" crossorigin="anonymous"></script><!-- Bootstrap --><link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/twitter-bootstrap/3.4.1/css/bootstrap.min.css" integrity="sha256-bZLfwXAP04zRMK2BjiO8iu9pf4FbLqX6zitd+tIvLhE=" crossorigin="anonymous">
<script src="https://cdnjs.cloudflare.com/ajax/libs/twitter-bootstrap/3.4.1/js/bootstrap.min.js" integrity="sha256-nuL8/2cJ5NDSSwnKD8VqreErSWHtnEP9E7AySL+1ev4=" crossorigin="anonymous"></script><!-- bootstrap-toc --><link rel="stylesheet" href="../bootstrap-toc.css">
<script src="../bootstrap-toc.js"></script><!-- Font Awesome icons --><link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.12.1/css/all.min.css" integrity="sha256-mmgLkCYLUQbXn0B1SRqzHar6dCnv9oZFPEC1g1cwlkk=" crossorigin="anonymous">
<link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.12.1/css/v4-shims.min.css" integrity="sha256-wZjR52fzng1pJHwx4aV2AO3yyTOXrcDW7jBpJtTwVxw=" crossorigin="anonymous">
<!-- clipboard.js --><script src="https://cdnjs.cloudflare.com/ajax/libs/clipboard.js/2.0.6/clipboard.min.js" integrity="sha256-inc5kl9MA1hkeYUt+EC3BhlIgyp/2jDIyBLS6k3UxPI=" crossorigin="anonymous"></script><!-- headroom.js --><script src="https://cdnjs.cloudflare.com/ajax/libs/headroom/0.11.0/headroom.min.js" integrity="sha256-AsUX4SJE1+yuDu5+mAVzJbuYNPHj/WroHuZ8Ir/CkE0=" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/headroom/0.11.0/jQuery.headroom.min.js" integrity="sha256-ZX/yNShbjqsohH1k95liqY9Gd8uOiE1S4vZc+9KQ1K4=" crossorigin="anonymous"></script><!-- pkgdown --><link href="../pkgdown.css" rel="stylesheet">
<script src="../pkgdown.js"></script><meta property="og:title" content="D1 Clinical trials concepts">
<meta property="og:description" content="YESCDS">
<!-- mathjax --><script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.5/MathJax.js" integrity="sha256-nvJJv9wWKEm88qvoQl9ekL2J+k/RWIsaSScxxlsrv8k=" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.5/config/TeX-AMS-MML_HTMLorMML.js" integrity="sha256-84DKXVJXs0/F8OTMzX4UR909+jtl4G7SPypPavF+GfA=" crossorigin="anonymous"></script><!--[if lt IE 9]>
<script src="https://oss.maxcdn.com/html5shiv/3.7.3/html5shiv.min.js"></script>
<script src="https://oss.maxcdn.com/respond/1.4.2/respond.min.js"></script>
<![endif]-->
</head>
<body data-spy="scroll" data-target="#toc">
    

    <div class="container template-article">
      <header><div class="navbar navbar-default navbar-fixed-top" role="navigation">
  <div class="container">
    <div class="navbar-header">
      <button type="button" class="navbar-toggle collapsed" data-toggle="collapse" data-target="#navbar" aria-expanded="false">
        <span class="sr-only">Toggle navigation</span>
        <span class="icon-bar"></span>
        <span class="icon-bar"></span>
        <span class="icon-bar"></span>
      </button>
      <span class="navbar-brand">
        <a class="navbar-link" href="../index.html">YESCDS</a>
        <span class="version label label-default" data-toggle="tooltip" data-placement="bottom" title="">0.0.26</span>
      </span>
    </div>

    <div id="navbar" class="navbar-collapse collapse">
      <ul class="nav navbar-nav">
<li>
  <a href="../reference/index.html">Reference</a>
</li>
<li class="dropdown">
  <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" data-bs-toggle="dropdown" aria-expanded="false">
    Articles
     
    <span class="caret"></span>
  </a>
  <ul class="dropdown-menu" role="menu">
<li>
      <a href="../articles/A1_cancer_table.html">A1 Cancers in my world</a>
    </li>
    <li>
      <a href="../articles/A2_rates.html">A2 Cancer rates for public health assessment</a>
    </li>
    <li>
      <a href="../articles/A3_monitoring.html">A3 Monitoring of cancer by public health institutions</a>
    </li>
    <li>
      <a href="../articles/A4_interactive_tables.html">A4 Using interactive tables</a>
    </li>
    <li>
      <a href="../articles/A5_data_graphics.html">A5 Data graphics</a>
    </li>
    <li>
      <a href="../articles/A6_standardization.html">A6 Age standardization of cancer rates</a>
    </li>
    <li>
      <a href="../articles/B1_global.html">B1 Cancer across the globe</a>
    </li>
    <li>
      <a href="../articles/B2_table_plus_geo.html">B2 Enhancing tables with geography</a>
    </li>
    <li>
      <a href="../articles/B3_counties.html">B3 Cancer in our counties</a>
    </li>
    <li>
      <a href="../articles/C1_body_overall.html">C1 Cancer in our bodies: Overall view</a>
    </li>
    <li>
      <a href="../articles/C2_variation_survival.html">C2 Variation in survival with cancer</a>
    </li>
    <li>
      <a href="../articles/C3_subtypes_molecular.html">C3 Molecular origins of diverse cancers</a>
    </li>
    <li>
      <a href="../articles/D1_clin_trial_concepts.html">D1 Clinical trials concepts</a>
    </li>
    <li>
      <a href="../articles/D2_equipoise.html">D2 Equipoise: when medical knowledge can only advance by experimenting</a>
    </li>
    <li>
      <a href="../articles/D3_randomization_bias.html">D3 Randomization to reduce bias</a>
    </li>
    <li>
      <a href="../articles/D4_comparing_trt.html">D4 Methods of comparing treatments</a>
    </li>
  </ul>
</li>
      </ul>
<ul class="nav navbar-nav navbar-right">
<li>
  <a href="https://github.com/vjcitn/YESCDS/">
    <span class="fab fa-github fa-lg"></span>
     
  </a>
</li>
      </ul>
</div>
<!--/.nav-collapse -->
  </div>
<!--/.container -->
</div>
<!--/.navbar -->

      

      </header><div class="row">
  <div class="col-md-9 contents">
    <div class="page-header toc-ignore">
      <h1 data-toc-skip>D1 Clinical trials concepts</h1>
                        <h4 data-toc-skip class="author">Vincent J. Carey, stvjc at channing.harvard.edu</h4>
            
            <h4 data-toc-skip class="date">June 30, 2022</h4>
      
      <small class="dont-index">Source: <a href="https://github.com/vjcitn/YESCDS/blob/HEAD/vignettes/D1_clin_trial_concepts.Rmd"><code>vignettes/D1_clin_trial_concepts.Rmd</code></a></small>
      <div class="hidden name"><code>D1_clin_trial_concepts.Rmd</code></div>

    </div>

    
    
<div class="section level2">
<h2 id="clinical-trials-for-cancer-treatments">Clinical trials for cancer treatments<a class="anchor" aria-label="anchor" href="#clinical-trials-for-cancer-treatments"></a>
</h2>
<ul>
<li><p>Despite massive investments in cancer research and treatment development, cancer remains a leading cause of death</p></li>
<li>We have examined many aspects of cancer’s diversity
<ul>
<li>tissue of origin</li>
<li>somatic mutations</li>
<li>response to treatment</li>
</ul>
</li>
<li>The main modalities of medical response to cancer are
<ul>
<li>surgery</li>
<li>chemotherapy</li>
<li>radiation</li>
</ul>
</li>
<li><p>Each of these modalities has a collection of subtypes, and they are often used in combination</p></li>
<li>How do doctors and patients navigate the available options?
<ul>
<li>Answer: interpret available data as evidence in favor of or against certain options</li>
</ul>
</li>
<li>The “gold standard” for evidence in medical decisionmaking is the randomized clinical trial (RCT)
<ul>
<li>Trials are generally preceded by “pre-clinical” studies of drugs or other treatment techniques</li>
<li>Analysis of data in pre-clinical research often demands great versatility of the statisticians and data scientists
<ul>
<li>such data are often sparse and noisy</li>
<li>ideally one integrates all available scientific information about the proposed alternative, requiring extensive literature search and acquisition of public data</li>
</ul>
</li>
</ul>
</li>
</ul>
</div>
<div class="section level2">
<h2 id="questions-to-answer-in-designing-a-clinical-trial-article">Questions to answer in designing a clinical trial <a href="https://www.cancer.org/treatment/treatments-and-side-effects/clinical-trials/what-you-need-to-know/phases-of-clinical-trials.html" class="external-link">(Article)</a><a class="anchor" aria-label="anchor" href="#questions-to-answer-in-designing-a-clinical-trial-article"></a>
</h2>
<ul>
<li>What is the current standard of care?<br>
</li>
<li>What care outcomes do we want to improve, and how much improvement would could as a real advance?
<ul>
<li>Here risk-benefit comparison becomes important</li>
</ul>
</li>
<li>What is the proposed alternative?</li>
<li>How do we determine a safe “dose” of the proposed alternative?
<ul>
<li>In the case of surgery this question may not make sense</li>
</ul>
</li>
<li>How do we verify that the proposed alternative has any effect at all?</li>
<li>How do we measure the overall benefit conferred by using the alternative method?</li>
</ul>
</div>
<div class="section level2">
<h2 id="the-typical-strategy-three-phases">The typical strategy: Three phases<a class="anchor" aria-label="anchor" href="#the-typical-strategy-three-phases"></a>
</h2>
<ul>
<li>Phase I: enroll healthy volunteers to do dose finding, assessing toxicity and side effects</li>
<li>Phase II: enroll patients with the disease and administer the maximum tolerated dose to establish that the new treatment has some beneficial effect</li>
<li>Phase III: enroll patients with the disease, but set up a comparison of the new treatment versus the standard of care
<ul>
<li>a design plan is produced detailing how many patients are to be enrolled, how the treatments will be administered, and how the data will be analyzed</li>
<li>patients are randomly assigned either the new treatment, or the standard of care</li>
<li>a Data Safety Monitoring Board will review study data periodically
<ul>
<li>studies may end prematurely if great benefit is seen early on, or if it appears no benefit could be documented by continuing the trial</li>
</ul>
</li>
</ul>
</li>
</ul>
</div>
<div class="section level2">
<h2 id="experimentation-with-human-subjects-is-carefully-regulated">Experimentation with human subjects is carefully regulated<a class="anchor" aria-label="anchor" href="#experimentation-with-human-subjects-is-carefully-regulated"></a>
</h2>
<p>The concept of <a href="https://www.cancer.org/treatment/treatments-and-side-effects/clinical-trials/what-you-need-to-know/what-does-a-clinical-trial-involve.html" class="external-link">informed consent</a> is central in the implementation of clinical trials.</p>
<p>The <a href="https://www.hhs.gov/ohrp/regulations-and-policy/belmont-report/index.html" class="external-link">Belmont report</a> defined principles and guidelines for all human subjects research.</p>
</div>
  </div>

  <div class="col-md-3 hidden-xs hidden-sm" id="pkgdown-sidebar">

        <nav id="toc" data-toggle="toc"><h2 data-toc-skip>Contents</h2>
    </nav>
</div>

</div>



      <footer><div class="copyright">
  <p></p>
<p>Developed by Vince Carey.</p>
</div>

<div class="pkgdown">
  <p></p>
<p>Site built with <a href="https://pkgdown.r-lib.org/" class="external-link">pkgdown</a> 2.0.4.</p>
</div>

      </footer>
</div>

  


  

  </body>
</html>
